Home NDC 50181-0074-1 Endopure Testos For Women
Product NDC 50181-0074
Requested package NDC 50181-0074-1
11-digit product format 501810074
Labeler code 50181
Product ID 50181-0074_5b1f1fd8-3a37-40bc-8600-7bb82c2670e6
Type HUMAN OTC DRUG
Nonproprietary name Hypothalamus Suis, RNA, Sabal Serrulata, DNA, Glandula Suprarenalis Suis, Hydrocortisone (Cortisol), Hypophysis Suis, Testosterone, Chelidonium Majus, Thuja Occidentalis
Dosage form LIQUID
Route ORAL
Labeler The Wellness Center for Research and Education, Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2021-04-19
Marketing end 0000-00-00
Substance SUS SCROFA HYPOTHALAMUS; SACCHAROMYCES CEREVISIAE RNA; SAW PALMETTO; HERRING SPERM DNA; SUS SCROFA ADRENAL GLAND; HYDROCORTISONE; SUS SCROFA PITUITARY GLAND; TESTOSTERONE; CHELIDONIUM MAJUS WHOLE; THUJA OCCIDENTALIS LEAFY TWIG
Active strength 6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
DEA schedule CIII
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 13 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50181-0074 ENDOPURE TESTOS FOR WOMEN (HYPOTHALAMUS SUIS, RNA, SABAL SERRULATA, DNA, GLANDULA SUPRARENALIS SUIS, HYDROCORTISONE (CORTISOL), HYPOPHYSIS SUIS, TESTOSTERONE, CHELIDONIUM MAJUS, THUJA OCCIDENTALIS) LIQUID [THE WELLNESS CENTER FOR RESEARCH AND EDUCATION, INC.] 1 Legacy NDC 20210420_04702cd6-ce49-43d2-bc5e-7a9e19815fe7.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50181-0074-1 50181007401 30 mL in 1 BOTTLE, DROPPER (50181-0074-1) 30 ml 2021-04-19 0000-00-00 No No Current